BioRestorative Therapies, Inc.
BRTXHealthcare|Biotechnology|US
$1.52
+0.01 (+0.66%)
Tangible Book / Share
$2.84
Cash / Share
$4.05
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT04042844 A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) | Lumbar Disc Disease | P2 | Recruiting | 99 | RCT, Double-blind | BRTX-100, Saline |